Medicine & Health

The Setton lab leads an interdisciplinary team researching potential treatments for intervertebral disc disease.

Research from the McKelvey School of Engineering highlights the interaction between MRI and focused ultrasound with microbubbles.

The stay-at-home orders during the peak of the COVID-19 pandemic in 2020 led to a decrease in children’s physical activity and in increase in screen time, finds two new studies from the Brown School.

Researchers in the McKelvey School of Engineering and at the University of Virginia recently developed a high-tech imaging technique that opens up opportunities to study dysfunction in acute and chronic kidney disease.

Julie O’Neal, assistant professor of medicine at the School of Medicine, received a $250,000 award from the International Myeloma Society. The award will be used to develop novel immunotherapy treatments for multiple myeloma, a common blood cancer.

A research team at Washington University School of Medicine has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.

The Division of Physician-Scientists at the School of Medicine has selected four physicians for its second class of Dean’s Scholars. The program provides up to two years of financial support and mentorship to aspiring, early-career physician-scientists, along with dedicated time for conducting laboratory research.

Antibiotic sales soared during India’s first surge of COVID-19, suggesting that the drugs were inappropriately used to treat mild and moderate COVID-19 infections, according to research led by the School of Medicine. Such overuse increases the risk for drug-resistant infections worldwide.

Kristen Kroll, professor of developmental biology at the School of Medicine, has received a four-year $2.1 million grant from the National Institutes of Health (NIH) for her project on human interneuron progenitor specification.

Researchers at Washington University School of Medicine have shown in preclinical studies that a natural killer cell-based immunotherapy could be effective against solid tumors such as melanoma.